Bibliotecas PUC-SP - Busca Integrada

WCN25-2522 ORIGIN Extend: A Long-Term Extension Study of Atacicept in IgAN

av Jonathan Barratt, Robert Brenner, Kerry Cooper, Xuelian Wei, Richard Lafayette
I publikationen Kidney International Reports (2025-02-01)

WCN24-1197 EFFICACY AND SAFETY OF RAVULIZUMAB IN A PHASE 2 RANDOMIZED CONTROLLED TRIAL IN IgA NEPHROPATHY

av Jonathan Barratt, Miguel Ángel Pérez Valdivia, Dario Roccatello, Katherine Garlo, Kara Rice, Richard Lafayette
I publikationen Kidney International Reports (2024-04-01)

An Open-Label Pilot Study of Adrenocorticotrophic Hormone in the Treatment of IgA Nephropathy at High Risk of Progression

av Ladan Zand, Pietro Canetta, Richard Lafayette, Nabeel Aslam, Novak Jan, Sanjeev Sethi, Fernando C. Fervenza
I publikationen Kidney International Reports (2020-01-01)

WCN24-1163 TREATMENT GOALS FROM THE PERSPECTIVE OF IMMUNOGLOBULIN A NEPHROPATHY PATIENTS - RESULTS FROM A REAL-WORLD STUDY

av Aneesh Thomas George, Richard Lafayette, Sydney Tang, Serge Smeets, Carolina Aldworth, Raymond Przybysz, Emma Chatterton
I publikationen Kidney International Reports (2024-04-01)

WCN24-1159 TREATMENT PATTERNS IN PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY - EVIDENCE FROM REAL-WORLD DATA

av Serge Smeets, Richard Lafayette, Sydney Tang, Carolina Aldworth, Raymond Przybysz, Aneesh Thomas George, Jonathan de Courcy
I publikationen Kidney International Reports (2024-04-01)

WCN24-1158 REAL-WORLD ANALYSIS OF PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY – DIAGNOSIS AND DISEASE MONITORING

av Serge Smeets, Richard Lafayette, Sydney Tang, Carolina Aldworth, Raymond Przybysz, Aneesh Thomas George, Jade Garratt-Wheeldon
I publikationen Kidney International Reports (2024-04-01)

Why Target the Gut to Treat IgA Nephropathy?

av Jonathan Barratt, Brad H. Rovin, Daniel Cattran, Jürgen Floege, Richard Lafayette, Vladimir Tesar, Hernán Trimarchi, Hong Zhang
I publikationen Kidney International Reports (2020-10-01)

Lenalidomide, melphalan and dexamethasone in a population of patients with immunoglobulin light chain amyloidosis with high rates of advanced cardiac involvement

av Shira Dinner, Wesley Witteles, Anosheh Afghahi, Ronald Witteles, Sally Arai, Richard Lafayette, Stanley L. Schrier, Michaela Liedtke
I publikationen Haematologica (2013-10-01)

The role of BAFF and APRIL in IgA nephropathy: pathogenic mechanisms and targeted therapies

av Chee Kay Cheung, Chee Kay Cheung, Jonathan Barratt, Jonathan Barratt, Adrian Liew, Hong Zhang, Vladimir Tesar, Richard Lafayette
I publikationen Frontiers in Nephrology (2024-02-01)

WCN24-342 ATACICEPT IN IGA NEPHROPATHY: CONTINUED PROTECTIVE TITERS TO DIPHTHERIA AND TETANUS AND BALANCED INFECTIONS VS PLACEBO WITH A FOCUS ON COVID-19

av Jonathan Barratt, Bart Maes, Rubeen Israni, Xuelian Wei, Vladimir Tesar, Gerald Appel, Yusuke Suzuki, Celia Lin, Richard Lafayette
I publikationen Kidney International Reports (2024-04-01)

WCN24-1799 HEMATURIA RESOLUTION WITH THE APRIL-BLOCKING MONOCLONAL ANTIBODY, SIBEPRENLIMAB, IN PATIENTS WITH IgA NEPHROPATHY IN A PHASE 2 RANDOMIZED CONTROLLED TRIAL

av Jonathan Barratt, Richard Lafayette, Hitoshi Suzuki, Sreelatha Melamadothil, Laura Kooeinga, Chula Herath, Muh Geot Wong, David Oldach, Asher Schachter, Mohit Mathur, Yusuke Suzuki
I publikationen Kidney International Reports (2024-04-01)

WCN24-1680 PREVALENCE AND CLINICAL CHARACTERISTICS OF KIDNEY TRANSPLANTS IN COMPLEMENT 3 GLOMERULOPATHY PATIENTS: RESULTS FROM A REAL-WORLD, MULTI-COUNTRY SURVEY

av Richard Lafayette, Raisa Sidhu, Clare Proudfoot, Katharina Pannagl, Briana Ndife, Serge Smeets, Kathleen Murphy, Raymond Przybysz, Jonathan de Courcy, Susanna Libby, Smeeta Sinha
I publikationen Kidney International Reports (2024-04-01)

WCN25-844 FELZARTAMAB FOR IgA NEPHROPATHY: FINAL RESULTS OF THE IGNAZ STUDY

av Uptal Patel, Jürgen Flöge, Jonathan Barratt, Richard Lafayette, Brian Schwartz, Paul Manser, Lisa Kivman, Stefan Ha¨rtle, Nicola Faulhaber, Anjali Thakur, Sean Barbour
I publikationen Kidney International Reports (2025-02-01)

WCN24-1294 ATACICEPT REDUCES HEMATURIA AND SERUM GD-IGA1, BOTH ASSOCIATED WITH LONG-TERM RENAL OUTCOMES IN IGA NEPHROPATHY: 36-WEEK RESULTS FROM THE PHASE 2B ORIGIN STUDY

av Jonathan Barratt, Bart Maes, Celia Lin, Xuelian Wei, Sean Barbour, Richard Phoon, Sung Gyun Kim, Vladimir Tesar, Jürgen Floege, Vivekanand Jha, Richard Lafayette
I publikationen Kidney International Reports (2024-04-01)

WCN24-1688 SELF-REPORTED QUALITY OF LIFE IN COMPLEMENT 3 GLOMERULOPATHY PATIENTS DELINEATED BY CKD STAGE: A REAL-WORLD, MULTI-COUNTRY SURVEY

av Richard Lafayette, Raisa Sidhu, Clare Proudfoot, Katharina Pannagl, Briana Ndife, Serge Smeets, Kathleen Murphy, Raymond Przybysz, Jonathan de Courcy, Susanna Libby, Smeeta Sinha
I publikationen Kidney International Reports (2024-04-01)

WCN24-1774 eGFR DECLINE IN PATIENTS WITH IgAN TREATED WITH NEFECON OR PLACEBO: RESULTS FROM THE 2-YEAR NefIgArd PHASE 3 TRIAL

av Richard Lafayette, Jens Kristensen, Andrew Stone, Jürgen Floege, Vladimír Tesař, Hernán Trimarchi, Hong Zhang, Necmi Eren, Alexander Paliege, Heather N. Reich, Brad H. Rovin, Jonathan Barratt
I publikationen Kidney International Reports (2024-04-01)

WCN24-1777 NEFECON TREATMENT PROVIDES KIDNEY BENEFITS FOR PATIENTS WITH IgAN THAT EXTEND TO THOSE WITH LOW LEVELS OF UPCR: A SUB-ANALYSIS OF THE PHASE III NefIgArd TRIAL

av Jonathan Barratt, Jens Kristensen, Andrew Stone, Jürgen Floege, Vladimír Tesař, Hernán Trimarchi, Hong Zhang, Necmi Eren, Alexander Paliege, Heather N. Reich, Brad H. Rovin, Richard Lafayette
I publikationen Kidney International Reports (2024-04-01)

WCN24-1674 NEFECON TREATMENT RESPONSE IN ASIAN AND WHITE PATIENT POPULATIONS WITH IMMUNOGLOBULIN A NEPHROPATHY: A 2YEAR ANALYSIS OF THE PHASE III NEFIGARD TRIAL

av Jonathan Barratt, Jens Kristensen, Andrew Stone, Jürgen Floege, Vladimír Tesař, Hernán Trimarchi, Hong Zhang, Necmi Eren, Alexander Paliege, Heather N. Reich, Brad H. Rovin, Richard Lafayette
I publikationen Kidney International Reports (2024-04-01)

WCN24-1414 ORIGIN 3: PIVOTAL PHASE 3 STUDY EVALUATING EFFECT OF ATACICEPT VS PLACEBO ON PROTEINURIA AND RENAL FUNCTION PRESERVATION IN IGA NEPHROPATHY

av Jonathan Barratt, Bart Maes, Rubeen Israni, Xuelian Wei, Jürgen Floege, Vivekanand Jha, Vladimir Tesar, Hong Zhang, Sean Barbour, Hitoshi Suzuki, Hernan Trimarchi, Celia Lin, Richard Lafayette
I publikationen Kidney International Reports (2024-04-01)

WCN24-1776 NEFECON EFFECT ON QUALITY OF LIFE IN PATIENTS WITH IgAN: SF-36 RESULTS FROM THE PHASE 3 NeFIgArd TRIAL

av Jonathan Barratt, Jens Kristensen, Andrew Stone, Jürgen Floege, Vladimír Tesař, Hernán Trimarchi, Hong Zhang, Necmi Eren, Alexander Paliege, Heather N. Reich, Brad H. Rovin, Richard Lafayette
I publikationen Kidney International Reports (2024-04-01)